Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
301 (1), G32G38
Primary Research: Primary research includes discussions with manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts
Understanding where each model sits helps operators evaluate which approach fits their brand, resources, and risk tolerance
Current law blocks Medicare weight-loss drug coverage Policy changes expected mid-2026 Medicaid coverage remains state-dependent What This Means for You Check your specific plan: Self-funded employers can still choose to cover Zepbound During open enrollment: Ask HR about 2026 GLP-1 coverage changes Consider alternatives: Wegovy is covered on most Aetna plans with similar efficacy Self-pay options: TrumpRx ($346/month), LillyDirect ($299-$449/month), or Foundayo (~$149/month oral GLP-1)
The injection technique stays the same
It contains structural changes that extend its half-life and reduce binding to IGF-binding proteins, allowing it to remain active in circulation longer than endogenous IGF-1
